Brian Tanquilut
Stock Analyst at Jefferies
(4.14)
# 440
Out of 5,149 analysts
144
Total ratings
62.75%
Success rate
10.01%
Average return
Main Sectors:
Stocks Rated by Brian Tanquilut
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ODD Oddity Tech | Downgrades: Hold | $64 → $18 | $12.35 | +45.75% | 2 | Feb 25, 2026 | |
| EHAB Enhabit | Downgrades: Hold | $13 → $14 | $13.60 | +1.47% | 5 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Buy | $250 → $265 | $242.88 | +9.11% | 11 | Feb 12, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $535 → $590 | $541.80 | +8.90% | 10 | Jan 28, 2026 | |
| COR Cencora | Upgrades: Buy | $330 → $440 | $371.44 | +18.46% | 1 | Jan 22, 2026 | |
| CHE Chemed | Downgrades: Hold | $550 → $475 | $424.16 | +11.99% | 3 | Jan 22, 2026 | |
| ACHC Acadia Healthcare Company | Downgrades: Hold | $34 → $15 | $22.99 | -34.75% | 6 | Jan 22, 2026 | |
| LMRI Lumexa Imaging Holdings | Initiates: Buy | $23 | $15.47 | +48.67% | 1 | Jan 5, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Buy | $11 → $13 | $7.28 | +71.70% | 4 | Oct 28, 2025 | |
| PNTG The Pennant Group | Initiates: Buy | $30 | $33.02 | -9.15% | 1 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $820 → $900 | $995.69 | -9.61% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $4.25 → $3 | $3.45 | -13.04% | 10 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $80 | $80.49 | -0.61% | 14 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $140 → $150 | $226.35 | -33.73% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $26 → $35 | $31.20 | +12.18% | 4 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $80 | $72.58 | +10.22% | 8 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $41 → $27 | $20.99 | +28.63% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $14.99 | -46.63% | 9 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $245 → $265 | $282.99 | -6.36% | 6 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $9 | $7.27 | +23.80% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $19.74 | -54.41% | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $40.65 | -55.72% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $140 → $155 | $208.36 | -25.61% | 6 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $21 | $8.98 | +133.85% | 4 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $8.5 → $14 | $21.30 | -34.27% | 6 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $26.63 | +68.98% | 1 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.70 | +270.37% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $23.77 | +38.83% | 1 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $0.57 | +6,068.49% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $103.36 | -27.44% | 1 | Aug 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $13 | $13.92 | -6.61% | 2 | Nov 1, 2017 |
Oddity Tech
Feb 25, 2026
Downgrades: Hold
Price Target: $64 → $18
Current: $12.35
Upside: +45.75%
Enhabit
Feb 23, 2026
Downgrades: Hold
Price Target: $13 → $14
Current: $13.60
Upside: +1.47%
Tenet Healthcare
Feb 12, 2026
Maintains: Buy
Price Target: $250 → $265
Current: $242.88
Upside: +9.11%
HCA Healthcare
Jan 28, 2026
Maintains: Buy
Price Target: $535 → $590
Current: $541.80
Upside: +8.90%
Cencora
Jan 22, 2026
Upgrades: Buy
Price Target: $330 → $440
Current: $371.44
Upside: +18.46%
Chemed
Jan 22, 2026
Downgrades: Hold
Price Target: $550 → $475
Current: $424.16
Upside: +11.99%
Acadia Healthcare Company
Jan 22, 2026
Downgrades: Hold
Price Target: $34 → $15
Current: $22.99
Upside: -34.75%
Lumexa Imaging Holdings
Jan 5, 2026
Initiates: Buy
Price Target: $23
Current: $15.47
Upside: +48.67%
Aveanna Healthcare Holdings
Oct 28, 2025
Maintains: Buy
Price Target: $11 → $13
Current: $7.28
Upside: +71.70%
The Pennant Group
Oct 24, 2025
Initiates: Buy
Price Target: $30
Current: $33.02
Upside: -9.15%
Oct 14, 2025
Maintains: Buy
Price Target: $820 → $900
Current: $995.69
Upside: -9.61%
Jul 24, 2025
Downgrades: Hold
Price Target: $4.25 → $3
Current: $3.45
Upside: -13.04%
Jun 30, 2025
Maintains: Buy
Price Target: $74 → $80
Current: $80.49
Upside: -0.61%
Feb 5, 2025
Upgrades: Buy
Price Target: $140 → $150
Current: $226.35
Upside: -33.73%
Jan 23, 2025
Upgrades: Buy
Price Target: $26 → $35
Current: $31.20
Upside: +12.18%
Jan 15, 2025
Maintains: Buy
Price Target: $100 → $80
Current: $72.58
Upside: +10.22%
Nov 13, 2024
Maintains: Hold
Price Target: $41 → $27
Current: $20.99
Upside: +28.63%
Oct 16, 2024
Initiates: Buy
Price Target: $8
Current: $14.99
Upside: -46.63%
Sep 23, 2024
Maintains: Buy
Price Target: $245 → $265
Current: $282.99
Upside: -6.36%
Mar 6, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $7.27
Upside: +23.80%
Mar 6, 2024
Maintains: Hold
Price Target: $10 → $9
Current: $19.74
Upside: -54.41%
Feb 20, 2024
Initiates: Buy
Price Target: $18
Current: $40.65
Upside: -55.72%
Feb 7, 2024
Upgrades: Buy
Price Target: $140 → $155
Current: $208.36
Upside: -25.61%
Nov 3, 2023
Downgrades: Hold
Price Target: $32 → $21
Current: $8.98
Upside: +133.85%
Mar 24, 2023
Upgrades: Hold
Price Target: $8.5 → $14
Current: $21.30
Upside: -34.27%
Nov 7, 2022
Assumes: Buy
Price Target: $45
Current: $26.63
Upside: +68.98%
Aug 15, 2022
Initiates: Buy
Price Target: $10
Current: $2.70
Upside: +270.37%
Jan 3, 2022
Initiates: Buy
Price Target: $33
Current: $23.77
Upside: +38.83%
Oct 20, 2021
Initiates: Buy
Price Target: $35
Current: $0.57
Upside: +6,068.49%
Aug 21, 2018
Initiates: Buy
Price Target: $75
Current: $103.36
Upside: -27.44%
Nov 1, 2017
Maintains: Buy
Price Target: $16 → $13
Current: $13.92
Upside: -6.61%